CIP2A and lip and oral cavity carcinoma: Moreover, the ability of the 599 peptide to mediate silencing of the CIP2A oncogene resulting in decreased oral cancer cell invasiveness and anchorage-independent growth demonstrate the therapeutic relevance of this delivery vehicle.